Centers, HSCD

Projects

Grants per year 1977 1987 1989 1992 1995 1998 2006 2009 2019

• 5 Active
• 47 Finished
• 102 Not started

Grants per year

Search results

• Finished

  Pancreatic Ductal Adenocarcinoma Targeted Ultrasound Contrast Agent Development

  Unger, E. C.

  3/15/16 → 2/28/17

  Project: Research project

  • Contrast Media 100%
  • Adenocarcinoma 95%
  • Chronic Pancreatitis 30%
  • Survival 22%
  • Peptides 17%

• Managing chemotherapy induced neuropathy in Cancer patients using ExerGaming

  Najafi, B. & Garland, L. L.

  3/14/16 → 2/28/18

  Project: Research project

  • Peripheral Nervous System Diseases 100%
  • Drug Therapy 79%
  • Gait 68%
  • Accidental Falls 31%
  • Exercise 30%

• Pim 1 Protein Kinase in Regulating Stromal Cell Biology in Prostate Cancer

  Kraft, A.

  6/1/15 → 5/31/17

  Project: Research project

  • Prostatic Neoplasms 100%
  • Prostate 90%
  • Myofibroblasts 82%
  • Growth 72%
  • Neoplasms 52%

• Targeting the Pim 1 Protein Kinase to Overcome Resistance to AKT Inhibitors

  Kraft, A.

  9/17/13 → 7/31/18

  Project: Research project

  • Prostatic Neoplasms 100%
  • Proto-Oncogene Proteins c-pim-1 86%
  • Receptor Protein-Tyrosine Kinases 84%
  • Protein Kinases 58%
  • Neoplasms 25%

• Metformin for Reduction of Obesity Associated Breast Cancer Risk

  Chow, H.

  9/11/13 → 6/30/19

  Project: Research project

  • Metformin 100%
  • Breast Neoplasms 59%
  • Adiposity 38%
  • Weight Gain 17%
  • Breast Density 17%

• Nsaid Effects on Clinical and Imaging Breast Biomarkers

  Stopeck, A. T. & Thompson, P.

  7/1/12 → 4/30/17

  Project: Research project

  • Aromatase Inhibitors 100%
  • Sulindac 91%
  • Breast Neoplasms 33%
  • Breast Density 26%
  • Anti-Inflammatory Agents 20%

• Development of Novel Sensitizer to Improve Response of Hypoxic Tumors to Radiatio

  Unger, E. C., Brown, J. M. & Scheck, A.

  5/24/10 → 8/31/16

  Project: Research project

  • Emulsions 100%
  • Tumor Hypoxia 70%
  • Head and Neck Neoplasms 53%
  • Neoplasms 46%
  • Radiotherapy 45%

• Novel Inhibitors of Pim Protein Kinases

  Kraft, A.

  9/7/09 → 5/31/11

  Project: Research project

  • Prostatic Neoplasms 100%
  • proto-oncogene proteins pim 99%
  • Protein Kinases 49%
  • Proto-Oncogene Proteins c-pim-1 32%
  • Capsules 32%

• Clinical Study of Disposition and Biological Activity of d-Limonene

  Chow, H.

  7/17/09 → 6/30/12

  Project: Research project

  • Limonene 100%
  • perillyl alcohol 27%
  • Breast 21%
  • Breast Neoplasms 18%
  • Carcinoma, Intraductal, Noninfiltrating 11%

• Prevention of UVB-induced skin cancer using sulforaphane: roles of AP-1 and Nrf2.

  Dickinson, S. R.

  9/29/08 → 8/31/14

  Project: Research project

  • Skin Neoplasms 100%
  • sulforafan 97%
  • Transcription Factor AP-1 53%
  • Carcinogenesis 37%
  • Skin 31%

• Non-Steroidal Anti-Inflammatory Drugs and Melanoma -- A Pooling Project

  Jeter, J. M.

  9/21/06 → 8/31/09

  Project: Research project

  • Melanoma 100%
  • Anti-Inflammatory Agents 73%
  • Pharmaceutical Preparations 41%
  • Health 29%
  • Chemoprevention 22%

• Breast Cancer Biomarkers for Risk and Detection (K01 Career Development Award)

  Frank, D. C.

  8/1/06 → 7/31/11

  Project: Research project

  • cancer 100%
  • biomarker 21%
  • abnormality 17%
  • trial 12%
  • didactics 10%

• DIFFUSION MRI AS BIOMARKER FOR THERAPY RESPONSE IN BREAST CANCER METASTASES

  Stopeck, A. T.

  7/14/06 → 5/30/13

  Project: Research project

  • Diffusion Magnetic Resonance Imaging 100%
  • Preliminary Data 46%
  • Biomarkers 41%
  • Breast Neoplasms 40%
  • Therapeutics 38%

• Redox-Active Agents for Pancreatic Cancer

  Dorr, R. T.

  5/1/06 → 12/31/10

  Project: Research project

  • 4-imino-1,3-diazabicyclo(3.1.0)hexan-2-one 100%
  • Pancreatic Neoplasms 60%
  • gemcitabine 47%
  • Oxidation-Reduction 27%
  • Metabolic Networks and Pathways 14%

• Pentostatin and Alemtuzumab for Allogeneic PBPCT

  Yeager, A. M.

  9/15/04 → 8/31/08

  Project: Research project

  • Pentostatin 100%
  • Alemtuzumab 91%
  • Tissue Donors 51%
  • Cell Transplantation 47%
  • Immunosuppressive Agents 36%

• Mechanisms by which Proteasome Enhance Apoptosis

  Kraft, A.

  3/1/04 → 2/28/09

  Project: Research project

  • apoptosis 100%
  • neoplasms 69%
  • neoplasm cells 49%
  • synergism 39%
  • receptors 36%

• Colorectal Screening Capacity Building Conference

  Alberts, S.

  9/1/03 → 8/31/04

  Project: Research project

  • Capacity Building 100%
  • Congresses 74%
  • Colorectal Neoplasms 29%
  • Medical Societies 24%
  • National Cancer Institute (U.S.) 21%

• Sonothrombolysis of Vascular Clots with Targeted Bubbles

  Matsunaga, T. O. & Unger, E. C.

  8/15/02 → 6/30/10

  Project: Research project

  • microbubbles 100%
  • vascular diseases 61%
  • blood vessels 51%
  • therapeutics 33%
  • death 32%

• Pim 1 protein kinase as a target for drug discovery

  Kraft, A.

  4/1/02 → 3/31/06

  Project: Research project

  • Protein Kinases 100%
  • Proto-Oncogene Proteins c-pim-1 84%
  • Drug Discovery 47%
  • Carcinogenesis 35%
  • Proto-Oncogene Proteins c-mdm2 25%

• Hollings Cancer Center Planning Grant

  Kraft, A. & Reed, C.

  8/24/01 → 7/31/07

  Project: Research project

  • neoplasms 100%
  • translational medical research 13%
  • prostatic neoplasms 11%
  • rural population 11%
  • health care workers 10%

• MOLECULAR CHEMOPREVENTION MECHANISMS OF TEA POLYPHENOLS

  Stratton, S. P.

  8/1/00 → 7/31/05

  Project: Research project

  • Polyphenol 100%
  • Chemopreventive 54%
  • Green 39%
  • Marker 33%
  • Stevens Reaction 30%

• DIFFUSION MRI AND CHEMOTHERAPEUTIC RESPONSE

  Stopeck, A. T.

  8/1/00 → 7/31/03

  Project: Research project

  • Diffusion Magnetic Resonance Imaging 100%
  • Water 56%
  • Drug Therapy 33%
  • Docetaxel 31%
  • Therapeutics 18%

• PHASE III TRIAL OF SELENIUM FOR PROSTATE CANCER PREVENT

  Ahmann, F. R. & Marshall, J.

  9/30/99 → 10/31/11

  Project: Research project

  • Prostatic Neoplasms 100%
  • Selenium 70%
  • Prostate-Specific Antigen 21%
  • Incidence 20%
  • Placebos 14%

• DIRECT NOSE/BRAIN DRUG/PEPTIDE TRANSPORT

  Chow, H.

  4/10/99 → 3/31/02

  Project: Research project

  • Nasal Cavity 100%
  • Brain 86%
  • Nose 71%
  • Peptides 65%
  • Pharmaceutical Preparations 42%

• PHASE I CLINICAL STUDIES OF POLYPHENOLS

  Alberts, S.

  9/30/98 → 9/29/01

  Project: Research project

  • Pharmacokinetics 100%
  • Healthy Volunteers 88%
  • epigallocatechin gallate 84%
  • Safety 77%
  • Polyphenols 73%

• REGULATION OF PROSTATE CANCER PROGRAMMED CELL DEATH

  Kraft, A.

  8/14/98 → 4/30/03

  Project: Research project

  • prostatic neoplasms 100%
  • apoptosis 77%
  • androgens 52%
  • neoplasm cells 28%
  • programmed cell death 23%

• CANCER PREVENTION AND CONTROL TRAINING GRANT

  Alberts, S., Marshall, J., Kittles, R. A., Harris, R. B., Harris, R. B. & Alberts, S.

  7/1/98 → 8/31/16

  Project: Research project

  • neoplasms 100%
  • public health 22%
  • mentoring 18%
  • uterine cervical neoplasms 16%
  • skin neoplasms 16%

• BRYOSTATIN 1 THERAPY OF METASTATIC MELANOMA

  Kraft, A.

  9/15/95 → 8/31/98

  Project: Research project

  • bryostatin 1 100%
  • Melanoma 33%
  • Protein Kinase C 12%
  • Bryostatins 11%
  • Pharmacology 8%

• DIFFERENTIATION THERAPY OF CHRONIC MYELOGENOUS LEUKEMIA

  Kraft, A.

  4/25/95 → 3/31/97

  Project: Research project

  • bryostatin 1 100%
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive 12%
  • Appointments and Schedules 9%
  • Hematopoietic System 7%
  • Lactones 7%

• PHOENIX LEADERSHIP MINI-SUMMIT

  Alberts, S.

  9/10/93 → 9/9/95

  Project: Research project

  • National Cancer Institute (U.S.) 100%
  • Breast Neoplasms 91%
  • Workplace 83%
  • Hispanic Americans 82%
  • Education 72%

• CLINICAL ONCOLOGY RESEARCH TRAINING

  Hersh, E. M. & Taetle, R.

  9/24/92 → 8/31/98

  Project: Research project

  • cancer 100%
  • training program 65%
  • trainee 50%
  • physician 41%
  • expertise 40%

• CYTOKINE REGULATION OF CHOLESTEROL TRAFFICKING

  Stopeck, A. T.

  7/1/92 → 6/30/98

  Project: Research project

  • Cholesterol 100%
  • LDL Receptors 52%
  • Cytokines 42%
  • Atherosclerosis 36%
  • Liver 35%

• FOURTH INTERNATIONAL CONFERENCE ON CANCER &NUTRITION

  Alberts, S.

  6/4/92 → 5/31/93

  Project: Research project

  • Congresses 100%
  • Neoplasms 65%
  • Chemoprevention 56%
  • Vitamins 50%
  • Tertiary Prevention 37%

• MECHANISM OF ACTION OF GM-CSF

  Kraft, A.

  3/1/92 → 11/30/01

  Project: Research project

  • Granulocyte-Macrophage Colony-Stimulating Factor 100%
  • Granulocyte-Macrophage Colony-Stimulating Factor Receptors 22%
  • Genetic Enhancer Elements 18%
  • Growth 18%
  • Genes 17%

• IMMUNOPHARMACOLOGIC ERADICATION OF MYELOID LEUKEMIA

  Yeager, A. M.

  2/20/92 → 11/30/98

  Project: Research project

  • myeloid leukemia 100%
  • bone marrow transplant 24%
  • cells 17%
  • leukemia 10%
  • stem cells 10%

• TUCSON LEADERSHIP SUMMIT--THE CHALLENGE OF BREAST CANCER

  Alberts, S.

  1/31/92 → 6/30/93

  Project: Research project

  • Breast Neoplasms 100%
  • Workplace 75%
  • Hispanic Americans 75%
  • National Cancer Institute (U.S.) 60%
  • Organizations 43%

• CANCER ETIOLOGY AND PREVENTION

  Alberts, S., Moon, T. & Ritenbaugh, C.

  6/1/90 → 2/28/03

  Project: Research project

• HUMAN MONOCLONAL ANTIBODIES TO HIV

  Hersh, E. M.

  12/1/89 → 11/30/92

  Project: Research project

  • Monoclonal Antibodies 100%
  • HIV 56%
  • HIV Antibodies 52%
  • Antibody-Dependent Cell Cytotoxicity 37%
  • Epitopes 35%

• LIPOSOMAL CONTRAST AGENTS FOR MR IMAGING

  Unger, E. C.

  9/30/89 → 2/28/93

  Project: Research project

  • magnetic resonance imaging 100%
  • image analysis 61%
  • neoplasms 57%
  • reticuloendothelial system 36%
  • scintigraphy 36%

• DRUG DISCOVERY GROUP FOR THE TREATMENT OF AIDS

  Hersh, E. M., Shannon, W., Stephens, E. B. & Chirigos, M.

  9/30/87 → 9/30/94

  Project: Research project

  • Drug Discovery 100%
  • Biomedical Research 78%
  • Acquired Immunodeficiency Syndrome 64%
  • Preclinical Drug Evaluations 46%
  • Contracts 45%

• TRANSPLANT STUDIES IN GLOBOID CELL LEUKODYSTROPHY

  Yeager, A. M.

  4/1/87 → 12/31/96

  Project: Research project

  • cell transplantation 100%
  • mice 30%
  • spinal cord 16%
  • brain 15%
  • enzyme replacement therapy 13%

• EX VIVO PHARMACOLOGIC PURGING IN LEUKEMIA

  Yeager, A. M.

  1/1/87 → 11/30/98

  Project: Research project

• CONTROL OF DIFFERENTIATION OF HUMAN PROMYELOCYTES

  Kraft, A.

  4/1/86 → 1/31/05

  Project: Research project

  • Phorbol Esters 100%
  • Bryostatins 98%
  • Phospholipids 80%
  • Calcium 53%
  • HL-60 Cells 52%

• TRANSPLANT THERAPY IN MURINE GLOBOID CELL LEUKODYSTROPHY

  Yeager, A. M.

  5/1/84 → 4/30/87

  Project: Research project

  • Globoid Cell Leukodystrophy 100%
  • Transplantation 82%
  • Galactosylceramidase 72%
  • Inborn Genetic Diseases 39%
  • Animal Models 31%

• STUDY OF ACQUIRED IMMUNODEFICIENCY AND KAPOSI'S SARCOMA

  Hersh, E. M.

  2/7/83 → 1/31/87

  Project: Research project

  • AIDS-Related Complex 100%
  • Acquired Immunodeficiency Syndrome 90%
  • Blood Banks 45%
  • Kaposi's Sarcoma 42%
  • Blood Donors 36%

• SOUTHWEST ONCOLOGY GROUP

  Miller, T. P. & Cranmer, L.

  1/1/78 → 12/31/14

  Project: Research project

  • Quality Control 100%
  • Neoplasms 66%
  • Continuing Education 62%
  • Patient Participation 58%
  • Vulnerable Populations 53%

• CLINICAL PHARMACOLOGY RESEARCH TRAINING

  Alberts, S. & Fagan, T.

  7/1/77 → 6/30/93

  Project: Research project